Insufficient evidence exists to recommend routine screening for chronic kidney disease (CKD) in asymptomatic adults, the United States Preventive Task Force (USPSTF) has concluded.

As Virginia A. Moyer, MD, MPH, and fellow USPSTF members reported online ahead of print in Annals of Internal Medicine, evidence that routine screening of CKD improves clinical outcomes for asymptomatic adults is inadequate, and evidence on the harms of such screening is inadequate.

Convincing evidence, however, shows that medications used to treat early CKD may have adverse effects.

Continue Reading